European Production Base Primex Pharmaceuticals is headquartered in Switzerland with all products manufactured in Europe, signaling a strong regional supply chain and potential for Europe-focused distribution partnerships and contract manufacturing opportunities.

Pediatric Expansion The company is expanding in paediatric pharmaceuticals and has a novel oral solution for pediatric sedation approved in several EU markets, presenting cross-sell opportunities to hospitals, clinics, and pediatric specialty distributors seeking paediatric anesthesia solutions.

Global Partner Network With a presence in over 40 countries through its global partner network, there are established channels for entering new markets, co-marketing deals, and channel partnerships to accelerate sales in additional regions.

Triad of Anesthesia Primex offers a complementary range of local anaesthetics and dental products under the OGNA brand, enabling bundled solutions and portfolio expansion conversations with anesthesia departments, dentists, and hospital procurement teams.

Growth & Leadership Recent leadership hires in business development and a history of revenue growth indicate a proactive growth strategy, suggesting readiness for channel partnerships, distribution agreements, and enterprise-level sales engagements to scale revenue.